V009-1716 Screening compound: N-{4-[3-(2,3-dihydro-1H-inden-5-yl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-4-hexylbenzamide

V009-1716 Screening compound: N-{4-[3-(2,3-dihydro-1H-inden-5-yl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-4-hexylbenzamide
V009-1716 Screening compound: N-{4-[3-(2,3-dihydro-1H-inden-5-yl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-4-hexylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-1716
N-{4-[3-(2,3-dihydro-1H-inden-5-yl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-4-hexylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-1716

Molecular Formula

C31H34N2O2S (C31 H34 N2 O2 S)

Compound Name

N-{4-[3-(2,3-dihydro-1H-inden-5-yl)-4-oxo-1,3-thiazolidin-2-yl]phenyl}-4-hexylbenzamide

IUPAC name

N-{4-[3-(23-dihydro-1H-inden-5-yl)-4-oxo-13-thiazolidin-2-yl]phenyl}-4-hexylbenzamide

SMILES

CCCCCCc(cc1)ccc1C(Nc1ccc(C(N2c3cc(CCC4)c4cc3)SCC2=O)cc1)=O

InChI

InChI=1S/C31H34N2O2S/c1-2-3-4-5-7-22-10-12-24(13-11-22)30(35)32-27-17-14-25(15-18-27)31-33(29(34)21-36-31)28-19-16-23-8-6-9-26(23)20-28/h10-20,31H,2-9,21H2,1H3,(H,32,35)/t31-/m0/s1

InChI Key

RYNJBRJNWMYJAE-HKBQPEDESA-N

MDL Number (MFCD)

MFCD19858536

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.69

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

7.950

Distribution Coefficient, logD

7.950

Water Solubility, LogSw

-5.65

Polar Surface Area

39.511

Acid Dissociation Constant (pKa)

10.99

Base Dissociation Constant (pKb)

-1.40

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.50

V009-1716 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
  • PPI modulators
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V009-1716 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-1716?
Check Price and Availability of V009-1716, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-1716 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-1716
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-1716
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-1716 available by request